Ghost Tree Capital, LLC Bluebird Bio, Inc. Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.32 - $4.83 $613,800 - $2.25 Million
465,000 New
465,000 $641,000
Q4 2018

Feb 14, 2019
SELL
$59.1 - $93.26 $4.43 Million - $6.99 Million
-75,000 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$88.86 - $117.49 $2.67 Million - $3.52 Million
-30,000 Reduced 28.57%
75,000 $11 Million
Q2 2018

Aug 14, 2018
BUY
$99.64 - $127.59 $10.5 Million - $13.4 Million
105,000 New
105,000 $16.5 Million

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $23.1M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email